The vast majority of animal viruses enhance membrane permeability at two moments of infection. Herein, we describe that the entry of Sindbis virus (SV) in BHK cells promotes the co-entry of the macromolecule alpha-sarcin into the cytoplasm, thereby blocking translation. At a later stage, this protein toxin cannot enter the cell, while low molecular weight compounds, such as hygromycin B, readily pass through the plasma membrane of Sindbis virus-infected BHK cells. To unveil the participation of the different Sindbis virus structural proteins in late permeabilization, transfection experiments with each late gene by separate have been carried out. Our findings indicate that 6K is the main determinant that enhances membrane permeabilization. The co-expression of both viral glycoproteins employing a Sindbis virus variant that lacks the entire 6K gene partly modifies membrane permeability. Brefeldin A, a macrolide antibiotic that interferes with the proper functioning of the vesicular system, hampers the induction of membrane leakiness without significantly affecting viral protein synthesis. On the other hand, the flavone compound Ro-090179 also diminishes the entry of hygromycin B, while bafilomycin A1 or nocodazole have no effect. These data reveal the requirement of the vesicular system for late viral membrane permeabilization.
Introduction
A large variety of animal viruses enhance membrane permeability during infection (Carrasco, 1994 (Carrasco, , 1995 Carrasco et al., 1993; Kelly et al., 2003) . To date, two different mechanisms of viral membrane permeabilization have been established: one occurring early in infection, in which the entry of virus particles into the cells leads to the co-entry of molecules present in the culture medium; and a later mechanism whereby the plasma membrane becomes leaky when the viral structural components are being synthesized (Carrasco, 1994 (Carrasco, , 1995 . Two different types of viral protein have been found to induce late membrane leakiness: glycoproteins with the ability to alter cell membrane permeability upon their expression (Arroyo et al., 1995; Ciccaglione et al., 2003; Comardelle et al., 1997; Chernomordik et al., 1994; Newton et al., 1997; Wengler et al., 2003) and small, very hydrophobic membrane proteins collectively known as viroporins (Carrasco, 1995; Gonzalez and Carrasco, 2003) . In addition, the HIV-1 protease is also able to induce cell lysis (Blanco et al., 2003) .
Sindbis virus (SV) belongs to the alphavirus genus and has a plus strand RNA as genome (Schlesinger et al., 2001; Strauss and Strauss, 1994) . SV infection starts by virion attachment to a cell receptor, followed by endocytosis, and low pH-mediated fusion of the viral envelope with the endosome membrane. Viral replication ensues in the cytoplasm. The newly made genomic RNAs are then encapsidated and the viral progeny egress by budding from the cell membrane. Alphavirus infection modifies a number of cellular processes such as membrane functioning, whereby intracellular monovalent cation levels are modified as SV infection progresses (Ulug et al., 1984) . The alphavirus Semliki Forest virus (SFV) also induces changes in cell permeability (Munoz et al., 1985) . The alphavirus 6K protein has been shown to be involved in membrane modification both in bacterial and mammalian cells (Melton et al., 2002; Sanz et al., 1994 Sanz et al., , 2003a . There is also direct evidence that 6K proteins from Ross River virus (RRV) and Barmah Forest virus (BFV) have the ability to form pores in artificial membranes (Melton et al., 2002) . Further, E1 seems to provoke membrane permeabilization in response to low pH-exposure in bacteria (Nyfeler et al., 2001) . During early stages of infection, E1 glycoprotein forms ionpermeable pores in endocytic membranes activated by low pH (Wengler et al., 2003) . The physical mechanism that leads to membrane permeabilization is still not fully understood. The fine details of this mechanism may differ according to the inducing molecule analyzed, although all these alphavirus proteins that alter permeability are capable of forming pores in membranes.
Bafilomycin A1, a selective inhibitor of vacuolar protonATPase (Drose and Altendorf, 1997) , blocks the co-entry of the toxin alpha-sarcin induced by several animal viruses, including SFV. The co-entry of macromolecules along with the virions requires the formation of a proton gradient (Guinea and Carrasco, 1995; Irurzun and Carrasco, 2001; . In accordance with these results, a model to explain these changes in early membrane permeability has been developed (Carrasco, 1994) although there are still a number of questions regarding the mechanisms of late membrane leakiness that need further clarification. For instance, it is not yet known if viroporins exert their permeabilization activity from an internal subcellular compartment or if physical pores are directly generated by viroporins at the plasma membrane. The immunolocalization of Coxsackie virus 2B protein reveals it mainly occurs at the Golgi apparatus (De Jong et al., 2003; van Kuppeveld et al., 1997) . Some authors have postulated that it may modify the plasma membrane indirectly from an internal cellular compartment (De Jong et al., 2003 . We now describe that an inhibitor of the vesicular system such as Brefeldin A (BFA) abolishes the enhancement of permeability during SV infection or its enhancement through the expression of the viroporin 6K. The results presented also lend support to the idea that 6K is a major determinant in this phenomenon, although viral glycoproteins also participate in membrane leakiness.
Results

Early and late cell permeabilization by SV
Most animal viruses permeabilize cells during the process of virus entry. As shown in Fig. 1 , this is also the case for SV. The virus particles specifically and efficiently promote the entry of alpha-sarcin (MW 16, 800) at early time points during infection, while the aminoglycoside antibiotic hygromycin B (HB) (MW 527) penetrates the cells less efficiently (Fig. 1B) . In the later stages of SV infection, when viral structural proteins are being synthesized, HB readily enters cells, whereas the macromolecule alpha-sarcin is excluded (Fig. 1C) . These findings are consistent with the idea that the enhanced membrane permeability observed late in the infection process is provoked by the presence of membrane pores that excluded the entry of macromolecules.
Viral products promoting late membrane leakiness
The precise contribution of the different SV structural proteins to enhancing late permeabilization is still unknown. To address this question, all late SV proteins were individually synthesized in BHK cells. Replication of the SV genome followed by the synthesis of protein C (see scheme rep C, Fig. 2A ) was insufficient to perturb the plasma membrane (Fig. 2B) . Besides, the constructs encoding C+PE2 (rep C + E3E2) and C + 6K (rep C + D(E3/E2)6K) were used and a new replicon encoding C + E1 (rep C + D(E3/E2)E1) was engineered. In the case of E1 and 6K constructs, they encode, in addition, the sequence D(E3/E2), which contained the 45 amino-terminal amino acids of E3 fused to 31 carboxy-terminal residues of E2.
Our rationale for including these extra sequences was based on the fact that the signal peptide driving the translocation of the nascent protein to the endoplasmic reticulum (ER) occurs at the N-terminal end of E3. Thus, in previous experiments, a construct that only coded for C and E1 produced an E1 product that was not translocated to the ER and was readily degraded (Sanz et al., 2003b) . The presence of D(E3/E2) not only promotes the correct translocation and insertion of E1 at the ER membrane, but also its proteolytic processing from 6K or E1 by ER signalases. The separate synthesis of each viral glycoprotein altered permeabilization to a limited extent (Fig. 2B) . Notably, the synthesis of 6K led to significant entry of the aminoglycoside antibiotic HB (Fig. 2B ). This antibiotic entry promoted by 6K led to a reduced percentage of translation that ranged from 1% to 6% as determined in four independent experiments. These data indicate that 6K is the main determinant of late membrane leakiness.
The 6K protein synthesized above contained a genuine sequence since the cleavage junction between E2 and 6K persisted. However, the product D(E3/E2) could in itself also exert some permeabilization activity. To address this, another 6K protein was engineered that lacks D(E3/E2) and bearing only four codons between C and 6K (see scheme rep C + 6K, Fig. 2A ). The four extra amino acids (SAHM) provide a cleavage site between C and 6K. This 6K permeabilized BHK cells to a similar extent as compared to D(E3/E2)6K (Fig. 2C ). This result suggests that 6K has an inherent ability to permeabilize cells even when synthesized out of the context of the viral polyprotein.
Once synthesized, alphavirus glycoproteins oligomerize to travel to the plasma membrane, giving rise to the typical spikes that participate in virus budding (Zhang et al., 2002) . Thus, we then went on to test the effects on permeabilization when both glycoproteins, E1 and E2, were synthesized together. To this end, we generated a 6K-deficient SV variant (D6K SV) that lacked the entire 6K gene. This SV variant retains the ability to process both glycoproteins and is able to form virus particles, albeit less efficiently than wt SV. BHK cells infected with the 6K-deleted variant exhibited a delayed cytopathic effect, as compared with cells infected with wt SV (Fig. 3A) . Despite this deletion, the 6K-deficient SV retained some of its ability to permeabilize cells (Fig. 3B) . Perhaps, this partial permeabilization activity is due to the accumulation of glycoproteins at the plasma membrane since virus budding is impaired in this SV variant.
BFA abolishes membrane permeabilization
An important issue to be considered is whether the viral products exert their permeabilization activity directly by forming pores at the plasma membrane, or if they act indirectly. In this last case, it has been speculated that viroporins, such as Coxsackie virus 2B protein, do not need to reach the plasma membrane and can alter membrane permeability from an intracellular compartment (De Jong et al., 2003 . If this is so, after synthesis, the viroporin may produce a signal that opens a cell pore already located at the plasma membrane. To get further insight into the action of 6K, we made use of the inhibitor BFA, a macrolide fungal antibiotic known to rapidly disorganize the Golgi complex and redistributes cis-, medial, and trans-Golgi markers into the ER (Klausner et al., 1992; LippincottSchwartz et al., 1989 LippincottSchwartz et al., , 1990 LippincottSchwartz et al., , 1991 Miller et al., 1992; Yewdell and Bennink, 1989) . The action of BFA has been explained by an inhibition of the anterograde vesicular traffic from ER to Golgi, between Golgi stacks, and from post-Golgi to plasma membrane, without effect on retrograde transport (Lippincott-Schwartz et al., 1989; Miller et al., 1992) . The molecular mechanism of action of BFA action is based on the inhibition of a subset of Sec7-type GTP-exchange factors (GEFs) that catalyze the activation of a small GTP-binding protein, ADP-ribosylation factor 1, or ARF1 (Jackson and Casanova, 2000) . This inhibition leads to the release from Golgi membranes of the COPI coat and AP-1/clathrin coat protein complexes implicated in the formation of transport vesicles (Scales et al., 2000) . BFA inhibits togavirus growth by blockade of proper glycoprotein processing and virus particle maturation. Contrary to effects in some picornaviruses, BFA does not inhibit the replication of alphavirus genomes (Irurzun et al., 1992; . Thus, the synthesis of late SV proteins is not impaired by the presence of BFA. Remarkably, the addition of BFA 2 h after infection impaired the permeabilization induced by SV infection (Fig. 4A) . The levels of synthesis of late virus proteins were similar in the absence or presence of BFA, indicating that the synthesis of viral proteins is insufficient to enhance membrane permeability. On the other hand, the antibiotic in itself has no direct inhibitory effect on membrane permeabilization, since the presence of BFA at the time of addition of the aminoglycoside HB did not affect its entry into cells (Fig. 4A) . The presence of BFA from 5 or 7 h post-infection only had a limited effect.
The effect of BFA on membrane permeabilization was also tested using the construct coding for C + 6K. Treatment of transfected BHK cells with BFA was also found to diminish the permeabilization capacity of 6K (Fig. 4B) . Our findings point to the idea that once synthesized, 6K has to travel or to send a signal through the vesicular system to reach the plasma membrane.
The inhibitory action of BFA in mammalian cells is reversible (Klausner et al., 1992; Miller et al., 1992) . Thus, to assess the reversibility of the BFA effect on membrane leakiness, SV infected BHK cells were treated with BFA from 2 to 6 h.p.i, when BFA was removed. Three hours later, the antibiotic HB readily entered the cytoplasm and inhibited translation as in the untreated cultures (Fig. 5) .
Finally, we also analyzed the activity of other compounds on SV permeabilization. SV-infected cells were incubated from 2 to 9 h.p.i with BFA, bafilomycin A1 (BFLA1), nocodazole (NOC) or Ro-090179 (Ro). Thus, BFLA1, a specific inhibitor of the vacuolar proton ATPase, and nocodazole, which binds tubulin and disaggregates the microtubule cytoskeleton (De Brabander et al., 1976; Thyberg and Moskalewski, 1999) , had no effect on SVinduced late permeabilization (Fig. 6) . Notably, the flavone compound Ro-090179, which interferes with the retrograde transport but has not effect on anterograde transport of the vesicular system (Sandoval and Carrasco, 1997) , diminished membrane permeabilization.
Discussion
Viral proteins that modify cell permeability can be broadly divided into two molecular groups: glycoproteins and viroporins (Gonzalez and Carrasco, 2003) . During virion entry, structural glycoproteins that contain the socalled fusion peptide promote the merging of viral and cellular membranes. At this stage of infection, early membrane permeabilization takes place once the virus has entered (Carrasco, 1994 (Carrasco, , 1995 Carrasco et al., 1993) . The co-entry of macromolecules into cells such as alpha-sarcin is most probably promoted by the glycoproteins present in the virions. Our findings reveal that small molecules such as the antibiotic hygromycin B, pass into the cell interior less efficiently at early time points during SV infection compared to late time points. The molecular basis of the co-entry of macromolecules is related to the proton motive gradient created in endosomes (Carrasco, 1994; Guinea and Carrasco, 1995; . On the other hand, late permeabilization is a consequence of viral gene expression late in infection. The synthesized glycoproteins usually form multimers that aggregate in the budding membranes to form a scaffold that wraps nucleocapsids. Viroporins also oligomerize at membranes leading to the formation of ion channels (Agirre et al., 2002; Ewart et al., 1996; Gonzalez and Carrasco, 2003; Melton et al., 2002; Nieva et al., 2003; Pinto et al., 1992; Premkumar et al., 2004) . Our present data indicate that the entry of HB late in SV infection may occur through the pores formed by the viral glycoproteins and viroporin 6K. These pores do not permit the passage of macromolecules such as alpha-sarcin. Thus, the molecular bases for the generation of early and late membrane permeabilization are different.
Protein 6K from alphavirus has the capacity to alter membranes both in bacteria and in mammalian cells (Sanz et al., 1994 (Sanz et al., , 2003a . Moreover, direct evidence has been found for pore formation by RRV and BFV 6Ks (Melton et al., 2002) . Based on genetic studies, the main function of viroporins including 6K involves correct virus particle morphogenesis and release from infected cells (Corse and Machamer, 2000; Hughey et al., 1992; Klimkait et al., 1990; Liljestrom et al., 1991; Loewy et al., 1995; Sanz and Carrasco, 2001; Sanz et al., 2003a) .The experiments reported here reveal that 6K plays a critical role in membrane permeabilization. Thus, the expression of SV non-structural genes and C has no effect on this phenomenon. Partial enhancement of permeabilization was observed when E3E2 (PE2) glycoproteins were synthesized, while much less activity was observed with E1 alone. Transport of E1 to the plasma membrane requires the co-expression of PE2 (Barth and Garoff, 1997; Barth et al., 1995; Sanz et al., 2003b) . If PE2 is individually expressed, transport to the plasma membrane is not impaired, but it may be unable to multimerize. Perhaps, the arrest of E1 in internal cellular compartments and the lack of proper multimerization for E2 could explain their lower permeabilizing capacity towards BHK cells. Interestingly, co-expression of both glycoproteins was more efficient at inducing the entry of the antibiotic HB. The synthesis of PE2 and E1 in the absence of 6K was achieved by infection with a mutant that lacks the entire 6K gene. This SV variant shows defects in virus budding, as described for an SFV 6K-deleted mutant (Liljestrom et al., 1991; Loewy et al., 1995) . Hence, it could be that oligomeric glycoproteins accumulate at the plasma membrane, leading to enhanced permeabilization.
Some viroporins including 6K from alphaviruses have not been immunodetected at the plasma membrane but have been observed in intracellular compartments (GaedigkNitschko and Schlesinger, 1990) . These findings have served as an argument for an indirect mechanism of action of viroporins (De Jong et al., 2003 . A few years ago, we found that BFA was an effective inhibitor of the membrane permeabilization promoted by poliovirus 2B (Oña, 2000) , this also occurred when avian reovirus p10 protein was analyzed (Bodelon et al., 2002) . Brefeldin A efficiently inhibits protein transport to the plasma membrane (Klausner et al., 1992; Lippincott-Schwartz et al., 1989; Miller et al., 1992; Yewdell and Bennink, 1989) . Having tested the effects of several agents on the membrane permeabilization that develops during SV infection, or upon expression of 6K, our results indicate that the flavone compound Ro-090179 and, to a greater extent, BFA are able to abrogate this altered membrane permeabilization. Despite the presence of SV proteins to control levels, no entry of HB is observed when BHK cells are treated with BFA. On the other hand, on its own BFA does not induce permeabilization and its effect is reversible after removal. These findings indicate that an intact vesicular system is necessary for membrane permeabilization by SV proteins.
Materials and methods
Cell culture and viruses
Baby hamster kidney (BHK-21) cells were grown at 37 8C in Dulbecco's Modified Eagle's medium (DMEM) supplemented with 5% fetal calf serum (FCS) and nonessential amino acids. Wild-type (wt) and 6K-deleted SV were propagated and titered in BHK-21 cultures.
Plasmids pT7SVwt (Sanz and Carrasco, 2001 ) and pT7SVE3+E2 (Sanz et al., 2003b) have been described previously.
pT7SVD6K has a full deletion of the 6K sequence. It was generated by inserting a PCR product digested with BssHII/ SplI into the same sites in pT7SVwt. The template used for both primary PCRs was pT7SVwt. In one of the primary reactions, we used a primer forward that had incorporated the restriction site BssHII (TGT AAA GCG CGC CGT GAG TGC) and a reverse primer containing the last 10 nucleotides of the E2 sequence plus the first 10 nts of E1 sequence (CAT GTT CGT AAG CAT TGG CC). The other primary PCR used the inverted and complementary sequence of the reverse primer described above as the primer forward and a negative sense primer that contained the SplI restriction site (ATT CGA CGT ACG CCT CAC TCA TCT). Both PCR products were used as templates in the secondary PCR with the outside oligonucleotides.
pT7SVC+D(E3/E2)E1 contains a deletion in the sequence coding for the E3 and E2 proteins. The remaining sequence codes for the 45 N-terminal amino acids of E3 fused to the 31 C-terminal amino acids of E2 followed by E1. The digested BssHII/SplI product from pT7SVD6K was inserted in the BssHII/SplI sites of pT7SV6K+E1 (Sanz et al., 2003b) .
Constructions corresponding to SV replicons rep C+D(E3/E2)6K and rep C have been previously described (Sanz et al., 2003a) .
The construction for the replicon rep C + 6K was made by inserting a PCR product that includes the 6K sequence after the C sequence in the plasmid for rep C. As a result of the cloning strategy, four codons encoding amino acids SAHM were introduced between C and 6K.
Transfection of BHK cells
BHK cells were electroporated with in vitro synthesized RNAs from the different plasmids. Subconfluent cells were harvested, washed in ice-cold phosphate-buffered saline (PBS), and resuspended in PBS at a density of about 2.5 Â 10 6 cell/ml. Fifty-microliter aliquots of T7 RNA polymerase (Promega) transcription mixture with about 100 Ag RNA from each different cDNA construct were added to 0.4 ml of cells, and the mixtures were transferred to 2 mm electroporation cuvettes (Bio-Rad). Electroporation was performed at room temperature as two consecutive 1.5-kV, 25-AF pulses using a Gene Pulser apparatus (Bio-Rad) as described elsewhere (Liljestrom et al., 1991) . Control BHK cells were electropored with 50 Al of transcription buffer in PBS. The cells were then diluted in growth medium and seeded onto culture plates.
Light microscopy
BHK cells were grown on glass cover slips and infected with wt SV or D6K SV at a multiplicity of infection of 10 pfu/cell. At 40 min post-infection, the virus medium was replaced with DMEM with 10% FCS. At 15 or 22 h postinfection (h.p.i), cells were washed with PBS and fixed with 4% (w/v) paraformaldehyde in PBS for 10 min at room temperature. Finally, cells were washed and mounted in moviol by inverting the coverslip and examined using an Axiovert 200 inverted microscope (Zeiss) with a 20 Â 0.6 Plan-Apochromat Ph2 objective lens.
Permeabilization assays in infected or electroporated BHK cells
Entry of the translation inhibitors hygromycin B (HB), or the RNAase alpha-sarcin (a gift from Dr. Schuurman, Michigan, USA) into the cells were used to detect permeabilization by radioactive labeling of proteins. Monolayers of BHK cells were infected with wt SV at a multiplicity of 100 pfu/cell or transfected with in vitro synthesized RNA from the different constructs. At several h.p.i or hours post-electroporation (h.p.e), the cultures were treated with 1 mM HB or 100 Ag/ml alpha-sarcin for 15 min, or left untreated. Next, proteins were labeled for 30 min with 200 Al methionine/cysteine-free DMEM supplemented with 1 Al Trans label [
35 S]Met-Cys (15 mCi/ml, Amersham Biosciences) per well in the presence or absence of the inhibitor. Cells were collected in buffer sample, boiled for 4 min and analyzed by SDS-PAGE and fluorography.
Inhibiting permeabilization by BFA treatment BHK cells were infected with 100 pfu/cell of wt SV. Then at 2, 5, 7, or 9 h.p.i, the culture medium was replaced with fresh medium containing 5 Ag/ml BFA as indicated in each experiment. At 9 h.p.i, cells were labeled in the presence or absence of 1 mM HB and BFA. Labeled proteins were separated by SDS-PAGE, as indicated above. The proteins in the gels were quantified by densitometry using a GS-710 calibrated Imaging Densitometer (Bio-Rad). A similar procedure was followed for the electroporated BHK cells using RNA from the constructs pT7rep C + 6K or pT7rep C. In this case, protein labeling was conducted at 16 h.p.e.
Effects of different compounds on SV induced permeabilization
Brefeldin A (5 Ag/ml) (BFA, Sigma), Bafilomycin A1 (1 AM) (BFLA1) (purchased from Dr. Altendorf, Osnabrqck University), NOC (40 AM) or Ro-090179 (10 Ag/ml) (a gift from Drs. Ishitsuka and Yokose, Nippon Roche Research Center, Kamakura, Japan) were added to the wt SV infected cultures at 2 h.p.i. Then at 9 h.p.i, the cultures were treated or not with 1 mM HB for 15 min followed by labeling of the proteins in the presence of the compounds with or without 1 mM HB. The samples were then subjected to SDS-PAGE.
